Vident Advisory LLC Buys 11,963 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Vident Advisory LLC significantly increased its holdings in HCA Healthcare by purchasing 11,963 shares, bringing its total ownership to 13,912 shares valued at approximately $4.8 million.
• HCA Healthcare recently declared a quarterly dividend of $0.72, with a yield of 0.7%, and has a payout ratio of 12.11%.
• Analysts have mixed ratings on HCA Healthcare, with a consensus rating of Moderate Buy and a target price of $401.83, reflecting diverse perspectives on the company's growth trajectory.

Vident Advisory LLC lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 613.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 13,912 shares of the company's stock after purchasing an additional 11,963 shares during the quarter. Vident Advisory LLC's holdings in HCA Healthcare were worth $4,808,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of HCA. Cheviot Value Management LLC bought a new stake in HCA Healthcare in the 1st quarter valued at approximately $26,000. WPG Advisers LLC bought a new stake in HCA Healthcare in the 1st quarter valued at approximately $27,000. Atwood & Palmer Inc. bought a new stake in HCA Healthcare in the 1st quarter valued at approximately $28,000. Bartlett & CO. Wealth Management LLC lifted its stake in HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after acquiring an additional 80 shares in the last quarter. Finally, ORG Partners LLC raised its stake in shares of HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares in the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Up 1.6%

Shares of HCA traded up $6.69 during mid-day trading on Friday, reaching $418.28. 304,150 shares of the company were exchanged, compared to its average volume of 1,533,732. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.20. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock has a market capitalization of $97.87 billion, a PE ratio of 17.57, a PEG ratio of 1.28 and a beta of 1.41. The business has a 50 day simple moving average of $379.31 and a two-hundred day simple moving average of $359.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter last year, the firm posted $5.50 earnings per share. The firm's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on HCA shares. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. JPMorgan Chase & Co. increased their price target on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Robert W. Baird increased their price target on HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research note on Thursday, August 14th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Finally, Morgan Stanley reduced their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $401.83.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.